• Logo

Daily Programme

Thursday, 20th July 2017

WORKSHOP: Acute pulmonary embolism to chronic thromboembolic pulmonary hypertension (CTEPH): State of the art management
(Organised in collaboration with the Pulmonary Vascular Research Institute)

0830-0900 Pulmonary embolism: A background
0900-0930 Case Discussion 1: Risk stratification
0930-1000 The role of imaging in pulmonary embolism
1000-1030 Management of confirmed pulmonary embolism
1030-1100 Coffee break
1100-1130 Case Discussion 2: To thrombolyse or not to thrombolyse? 
1130-1200 Case Discussion 3: The argument for and against lifelong anticoagulation
1200-1230 Management of bleeding in anti-coagulated patients
1230-1330 Lunch break
1330-1400 Case Discussion 4: CTEPH – an easily missed-diagnosis
1400-1430 Investigating suspected CTEPH
1430-1500 Medical intervention for CTEPH – do the drugs work?
1500-1515 Coffee break
1515-1545 Balloon pulmonary angioplasty
1545-1615 The surgical approach to CTEPH
1615 Close
1630-1730 Meeting of Pulmonary Vascular Research Institute Regional Taskforce
1730-1830

Sponsored Symposium 1 (SS1)
ResMed

Big data - the new cornerstone of precision medicine
– Mr Brett McLaren

Friday, 21st July 2017

0700-0800 Registration
0800-0810

Welcome Address by:

  • Prof Dr Roslina Abdul Manap
    President, Malaysian Thoracic Society
     
  • Dr Nurhayati Mohd Marzuki
    Organising Chairperson, MTS Annual Congress 2017
0810-0850

PLENARY 1 (P1)

The Future of Pulmonary Hypertension
– Prof Dr Paul Corris

Chairperson: Prof Roslina Abdul Manap

0850-1005

SYMPOSIUM 1 (S1)

S1A – Occupational and Environmental Lung Disease

  1. The impact of environmental factors on lung defences – Dr Roslan Harun
  2. Climate change and lung disease – Dr Hooi Lai Ngoh
  3. Occupational ILD – Assoc Prof Dr Victor CW Hoe

S1B – Ethics and Medicolegal Matters

  1. Palliative care: when, where and how? – Dr Lam Chee Loong
  2. Implementing a culture of safety – Mr Vivek Anand
  3. Combating pseudoscience – Dr Suhazeli Abdullah

S1C – Difficult asthma in children

  1. Children with difficult asthma, who are they? – Prof Dr Dominic Fitzgerald
  2. Severe allergic asthma – Dr Rus Anida Awang
  3. Recognizing and managing brittle asthma in children – Prof Dr Dominic Fitzgerald
1005-1035 Coffee break
1035-1150 

SYMPOSIUM 2 (S2)

S2A – Tuberculosis I

  1. Review of National Tuberculosis Control Programme – Dr Mohamad Naim Abdul Kadir
  2. Patient-centred TB care – Ms Mildred Fernando
  3. Contact tracing and Latent TB infection in children – Dr Tan Kah Kee

S2B – Pulmonary manifestations of systemic disease

  1. Sarcoidosis – Dr Anantham Devanand
  2. Pleural disease – Dr Fauzi Anshar
  3. Lung-dominant connective tissue disease – Assoc Prof Raja Jasmin

S2C – Inherited Metabolic and Genetic Diseases in children

  1. Inherited Metabolic diseases: What the paediatrician should know? – Dr Ngu Lock Hock
  2. Inherited Metabolic diseases: Management of respiratory complications – Dr Su Siew Choo
  3. Congenital skeletal abnormalities and respiratory insufficiency – Prof Thong Meow Keong
1150-1240

SPONSORED SYMPOSIUM 2 (SS2)
Company: AstraZeneca

Asthma: Time to Up Our Game
– Prof Martyn Partridge

1240-1430 Lunch and Friday prayers
1430-1600

SYMPOSIUM 3 (S3)

S3A – Pleural Disease

  1. Malignant pleural effusion: AMPLE TIME or ASAP – Prof Dr Gary Lee
  2. Empyema – Dr Asma Navasakulpong
  3. VATS - when to call a surgeon – Dr K.M. John Chan

S3B – Sleep-disordered breathing

  1. Obstructive sleep apnoea and the metabolic syndrome – Dr Ahmad Izuanuddin Ismail
  2. When to call a neurologist – Prof Dr Nortina Shahrizaila
  3. Obesity Hypoventilation Syndrome – Dr Lalitha Pereirasamy

S3C – Primary immumedeficiency (PID) and respiratory complications

  1. Overview of Primary immunodeficiency disease – Prof Lokman Mohd Noh
  2. Laboratory investigations in Primary Immunodeficiency disease – Dr Adiratna Mat Ripen
  3. Respiratory complications in Primary Immunodeficiency disease – Dr Dayang Zuraini Sahadan
  4. Optimal management for children with Primary Immunodeficiency disease – Assoc Prof Intan Hakimah Ismail
1600-1650

SPONSORED SYMPOSIUM 3A (SS3A)
Company: GlaxoSmithKline Pharmaceutical

Expert Discussion on efficacy of bronchodilators and inhaler devices for COPD Management
– Prof Dato’ Dr Hj Abdul Razak Muttalif
– Dr Ahmad Izuanuddin Ismail

SPONSORED SYMPOSIUM 3B (SS3B)
Company: Sanofi Pasteur 
Influenza disease burden in chronic respiratory patients and the role of influenza vaccination
– Assoc Prof Dr Pang Yong Kek

1650-1845 Coffee break and MTS Annual General Meeting
1845-1935

SPONSORED SYMPOSIUM 4A (SS4A)
Company: Roche
Biomarkers in lung cancer. How they support imaging, differential diagnosis and treatment monitoring 
– Prof. Dr. Rafael Molina

SPONSORED SYMPOSIUM 4B (SS4B)
Company: Pfizer
Defining the role of A 5th Generation Cephalosporin In CAP 
– Prof Thomas P. Lodise

1935-2200 Dinner

Saturday, 22nd July 2017

0700-0800

Sunrise Session: Emerging treatments for bronchiectasis
– Asst Prof Dr Sanjay Chotirmall

0800-0840

PLENARY 2 (P2)

Lung disease of prematurity and long term outcome 
– Prof Dr Dominic Fitzgerald

0840-1010

SYMPOSIUM 4 (S4)

S4A - Asthma

  1. Difficult asthma: What is it and what to think about before escalating treatment? – Prof Martyn Partridge
  2. The role of biomarkers in asthma management – Dr Hilmi Lockman
  3. Improving patient outcomes in asthma – Dr Helmy Haja Mydin

S4B - Non-invasive ventilation

  1. The role of transnasal insufflation – Dr Sewa Duu Wen
  2. Home BiPaP in the management of COPD – Dr Kow Ken Siong
  3. Neuromuscular diseases – Dr Asiah Kassim

S4C - Current Childhood Asthma Phenotypes

  1. Asthma phenotypes in children – Assoc Prof Jessie Anne de Bruyne
  2. Genetics in childhood asthma – Dr Alison Ting Yih Hua
  3. Phenotype focused management, is it practical? – Prof Dr Dominic Fitzgerald
1010-1040 Coffee break
1040-1210

SYMPOSIUM 5 (S5)

S5A - Lung cancer

  1. Lung cancer screening – Dr Anantham Devanand
  2. Re-biopsies in known cases of lung cancer – Dr Pathmanathan Rajadurai
  3. Immunotherapy in lung cancer – Prof Liam Chong Kin

S5B - Respiratory infections

  1. MDRO in the critically ill – Dato' Dr Mahiran Mustafa
  2. Me, Myself and my microbes: A precision approach to the lung microbiome – Asst Prof Sanjay Chotirmall
  3. Preparing for the next flu pandemic – Dr Nurhayati Rosli

S5C - Congenital airway and diaphragm defects in children

  1. Congenital airway and diaphragm defects: From common to rare – Dato Dr Zakaria Zahari
  2. Acute management of diaphragmatic defects – Prof Lucy CS Lum
  3. Intermediate and long-term complications of diaphragmatic defects – Assoc Prof Surendran Thavagnanam

1210-1300

SPONSORED SYMPOSIUM 5 (SS5)
Company: Boehringer Ingelheim

Heritage Meets Innovation – Meeting patient’s needs in the changing world of COPD management
– Prof Klaus Rabe

1300-1400 Lunch
1400-1530

Adult Multi-disciplinary case discussions

  • Case 1:
    Presenter: Dr Nurashikin Mohammad
    Radiologist: Dr Zuhanis Abdul Hamid
    Respiratory Physician: Dr Andrea Ban Yu-Lin
     
  • Case 2: 
    Presenter: Dr Muhammad Amin Ibrahim 
    Radiologist: Dr Zuhanis Abdul Hamid
    Pathologist: Dr Nor Salmah Bakar
    ​Respiratory Physician: Dr Mohd Arif Mohd Zim
     
  • Case 3: 
    Presenter: Dr Zul Amali Che Kamaruddin
    Radiologist: Dr Zuhanis Abdul Hamid
    Pathologist: Dr Nor Salmah Bakar
    Respiratory Physician: Dr Azza Omar
     

Paediatric Multi-disciplinary case discussions

  • Case 1: 
    Presenter: Dr Nurul Zamil Mohd Muzzamil
    Radiologist: Assoc Prof Dr Roziah Muridan
    Respiratory Paediatrician: Dr Mariana Daud
     
  • Case 2: 
    Presenter: Dr Mohd Shafie Hashim
    Radiologist: Assoc Prof Dr Roziah Muridan
    Respiratory Paediatrician: Dr Mariana Daud
     
1530-1630 CONCURRENT ORAL AND POSTER PRESENTATIONS
1630-1720

SPONSORED SYMPOSIUM 6 (SS6)
Company: Novartis

Importance of exacerbation prevention in COPD
– Prof Dr Kai- Michael Beeh

1720-1740 Coffee break
1740-1830

SPONSORED SYMPOSIUM 7 (SS7)
Company: GlaxoSmithKline Pharmaceutical

Is Once Daily the practical choice for asthma maintenance?
– Dr Celeste Mae Lardizabal-Campomanes

2000-2200

MTS GALA DINNER

Launch of Asthma Malaysia
Launch of LFM Coffee table book
Prize giving for best paper and poster awards

SUNDAY, 23rd July 2017

0700-0800

Sunrise Session: ATS Discovery Series: Mechanical Ventilation: From Vesalius to VILI
– Dr Arthur Slutsky

0800-0840

PLENARY 3 (P3)
The National Strategic Plan for Tobacco Control
– Dr Noraryana Hassan

0840-1010

SYMPOSIUM 6 (S6)

S6A - Tuberculosis II

  1. Drug-resistant TB – Dr Maria Tarcela Gler
  2. HIV/TB co-infection – Dr Leong Kar Nim
  3. New drugs and regimens for TB treatment – Dr Maria Tarcela Gler

S6B - Interventional Respiratory Techniques

  1. Navigational bronchoscopy – Assoc Prof Tidi Hassan
  2. Pleural interventions – Prof Dr Gary Lee
  3. Airway stenting – Prof How Soon Hin

S6C (Paediatrics) - Craniofacial deformity and its impact on the respiratory system

  1. Common craniofacial syndromes and their comorbidities – Mr Mohd Ali Mat Zain
  2. Management of airway complications in craniofacial syndromes – Assoc Prof Anna Marie Nathan
  3. Management of other co-morbidities in craniofacial syndromes – Mr Azmi Alias

1010-1130

Coffee break
1040-1130

SPONSORED SYMPOSIUM 8 (SS8)
Company: Mundipharma

breatheriteTM: Your Digital Education & Solutions in Respiratory Care

1130-1230 Forum: The role of clinicians in patient advocacy
1230-1240 Closing Ceremony
1240-1410 Lunch

The Venue

Sunway Putra Hotel - It is a renowned 5-star international hotel in Kuala Lumpur offers business & leisure travellers a homelike experience.

Address: 100 Jalan Putra, 50350 Kuala Lumpur, Malaysia
Tel: 603 4040 9888
Fax: 603 4043 0700
Website: www.putra.sunwayhotel.com